Cargando...
Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?
Conventional transarterial chemoembolization (c-TACE) was validated in 2002 for intermediate stage hepatocellular carcinoma (HCC). Recent improvements in overall survival after c-TACE in HCC is linked to both better patient selection, and improvement in treatment technologies: catheter, image guidan...
Gardado en:
| Publicado en: | Hepat Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095432/ https://ncbi.nlm.nih.gov/pubmed/30191032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2015-0001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|